According to the lawsuit, throughout the Class Period, Evolv and its senior management failed to alert investors that the Company’s financial statements contained material misstatements relating to Evolv's revenue recognition and other revenue-related metrics.

On October 25, 2024, Evolv announced that the Company's financial statements issued between the second quarter of 2022 and the second quarter of 2024 should not be relied upon due to material misstatements impacting revenue recognition. The Company revealed that certain sales, including sales to one of its largest channel partners, were subject to extra-contractual terms not shared with the Company's accounting personnel and that certain Evolv personnel had engaged in misconduct. The Company further announced that it had self-reported these issues to the Securities and Exchange Commission.

On this news, the price of Evolv stock declined approximately 40%, from a close of $4.10 per share on October 24, 2024, to a close of $2.47 per share on October 25, 2024.

On October 31, 2024, Evolv announced the termination of its CEO, Peter George, effective immediately. On this news, the price of Evolv stock declined approximately 8%, from a close of $2.34 per share on October 30, 2024, to a close of $2.15 per share on October 31, 2024.

Investors who purchased or acquired Evolv securities between August 19, 2022 through October 30, 2024, may no later than December 31, 2024, seek to be appointed as a lead plaintiff representative of the class.